Developing Peer Review System for a Small Journal – The KJP Experience
https://doi.org/10.30834/KJP.28.1.2015.25
HTML
PDF

References

Shaji S, Promodu K, Abraham T, Roy KJ, Verghese A. An epidemiological study of dementia in a rural community in Kerala, India. Br J Psychiatry 1996; 168(6):745-9.

Shaji S, Bose S, Verghese A. Prevalence of dementia in an urban population in Kerala, India. Br J Psychiatry 2005; 186:136-40.

Rennie D. Editorial peer review: its development and rationale. In: Godlee F, Jefferson T, editors. Peer Review in Health Sciences. 2nd ed. London: BMJ Publishing Group; 2003. pp. 1-13.

Armstrong JS. Peer review for journals: evidence on quality control, fairness, and innovation. Sci Eng Ethics 1997; 3:63–84.

Kassirer JP, Campion EW. Peer review. Crude and understudied, but indispensable. JAMA 1994; 272:96–7.

Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med1994; 121:11–21.

Marušic′ A, Lukic′ IK, Marušic′ M, McNamee D, Sharp D, Horton R. Peer review in a small and a big medical journal: case study of the Croatian Medical Journal and The Lancet. Croat Med J 1992; 43:286–9.

Callaham M. The evaluation and training of peer reviewers. In: Peer Review in Health Sciences (Second edition). In: Godlee F, Jefferson T, editors. Peer Review in Health Sciences. 2nd ed. London: BMJ Publishing Group; 2003. pp. 164-82.

Godlee F, Jefferson T, editors. Peer Review in Health Sciences. 2nd ed. London: BMJ Publishing Group; 2003.

Hames I. Peer review and manuscript management in scientific journals. Malden MA: Blackwell Publishing; 2007.

Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61(4):344-9.

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6(6): e1000097. doi:10.1371/journal.pmed1000097

Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep 2013; doi:10.1136/bcr-2013-201554

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239–45.